港股收盘(07.18) | 恒指收涨1.33% 稳定币概念多数走高 AI概念、医药股再度发力

Market Overview - Hong Kong stocks experienced a rebound with all three major indices rising over 1%, closing with the Hang Seng Index up 1.33% at 24,825.66 points and a total trading volume of HKD 238.69 billion [1] - For the week, the Hang Seng Index increased by 2.84%, the Hang Seng China Enterprises Index rose by 3.44%, and the Hang Seng Tech Index gained 5.53% [1] - The recent geopolitical tensions in the Middle East have eased, and there is a marginal improvement in US-China relations, contributing to a recovery in global market risk appetite [1] Blue Chip Performance - ZTO Express (02057) led blue-chip stocks with a rise of 6.51%, closing at HKD 152.1, contributing 6.54 points to the Hang Seng Index [2] - China Life (02628) increased by 5.13%, contributing 11.32 points, while Hansoh Pharmaceutical (03692) rose by 4.49%, contributing 2.86 points [2] - Xinyi Solar (00968) fell by 3.41%, detracting 0.75 points from the index, and Galaxy Entertainment (00027) decreased by 0.93%, detracting 1.2 points [2] Sector Highlights Stablecoin Sector - Stablecoin-related stocks saw significant gains following the US Congress's approval of the Stablecoin Innovation Act, with Yao Cai Securities Financial (01428) rising by 16.93% and Yunfeng Financial (00376) up by 15% [3] - The act aims to establish a clear legal framework for stablecoins, which is expected to enhance the compliance and development of the stablecoin industry [3] AI Sector - AI-related stocks were active, with Huya Technology (01860) rising by 15.56% and Innovation Works (02121) increasing by 10.39% [4] - The recent launch of the K2 model by Moonlight Kimi and OpenAI's ChatGPT Agent has sparked interest in AI advancements, with analysts optimistic about the sector's growth potential [4] Pharmaceutical Sector - The pharmaceutical sector showed strong performance, with Lepu Biopharma (02157) surging by 24.65% and Genscript Biotech (01672) rising by 17.97% [4] - Morgan Stanley noted a significant rebound in China's healthcare sector, with the MSCI China Healthcare Index up approximately 50% this year [5] Brokerage and Insurance Stocks - Brokerage and insurance stocks also saw gains, with GF Securities (01776) up by 5.04% and China Life (02628) increasing by 5.13% [6] - Recent policies aimed at guiding insurance funds towards long-term stable investments are expected to enhance the profitability of insurance companies [6] Notable Stock Movements - China New Economy Investment (00080) surged by 394.38% after announcing a mandatory cash offer for shares [7] - Chuangmeng Tiandi (01119) rose by 30.12% following a profit forecast indicating a turnaround [8] - Dongfang Zhenxuan (01797) increased by 12.78% due to new product launches [9] - CATL (03750) reached a new high, with Goldman Sachs projecting strong revenue and profit growth [10] - Kintor Pharmaceutical (01888) fell by 9.23% after announcing a share placement at a discount [11]